XML 36 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Follow-on Offering
Common Stock
Common Stock
Follow-on Offering
Additional Paid-In Capital
Additional Paid-In Capital
Follow-on Offering
Accumulated Other Comprehensive Income/ (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2015 $ 93,873   $ 3   $ 158,555     $ (64,685)
Beginning balance, shares at Dec. 31, 2015     27,053,156          
Impact of implementation/ Cumulative effect adjustment upon adoption | ASU 2014-09 (2,772)             (2,772)
Issuance of common stock during offering, net of issuance costs, value   $ 61,110       $ 61,110    
Issuance of common stock during offering, net of issuance costs, shares       4,370,000        
Issuance of common stock upon the exercise of options and purchases under employee stock purchase plan, value 506       506      
Issuance of common stock upon the exercise of options and purchases under employee stock purchase plan, shares     71,826          
Repurchase of early exercised stock options, value (48)       (48)      
Repurchase of early exercised stock options, shares     (65,984)          
Vesting of early exercised stock options and restricted stock 272       272      
Stock-based compensation 2,813       2,813      
Unrealized gains/(losses), net of tax benefits 8           $ 8  
Net loss (10,380)             (10,380)
Ending balance at Dec. 31, 2016 145,382   $ 3   223,208   8 (77,837)
Ending balance, shares at Dec. 31, 2016     31,428,998          
Impact of implementation/ Cumulative effect adjustment upon adoption | ASU 2016-09         8     (8)
Issuance of common stock during offering, net of issuance costs, value   133,862   $ 1   133,861    
Issuance of common stock during offering, net of issuance costs, shares       4,025,000        
Issuance of common stock upon the exercise of options and purchases under employee stock purchase plan, value 2,365       2,365      
Issuance of common stock upon the exercise of options and purchases under employee stock purchase plan, shares     400,754          
Repurchase of early exercised stock options, value (45)       (45)      
Repurchase of early exercised stock options, shares     (41,961)          
Vesting of early exercised stock options and restricted stock 184       184      
Stock-based compensation 6,138       6,138      
Unrealized gains/(losses), net of tax benefits (200)           (200)  
Net loss (57,010)             (57,010)
Ending balance at Dec. 31, 2017 230,676   $ 4   365,719   (192) (134,855)
Ending balance, shares at Dec. 31, 2017     35,812,791          
Issuance of common stock during offering, net of issuance costs, value   $ 181,863       $ 181,863    
Issuance of common stock during offering, net of issuance costs, shares       3,961,147        
Issuance of common stock upon the exercise of options and purchases under employee stock purchase plan, value 6,208       6,208      
Issuance of common stock upon the exercise of options and purchases under employee stock purchase plan, shares     516,008          
Repurchase of early exercised stock options, value (1)       (1)      
Repurchase of early exercised stock options, shares     (997)          
Vesting of early exercised stock options and restricted stock 53       53      
Stock-based compensation 19,341       19,341      
Unrealized gains/(losses), net of tax benefits 125           125  
Net loss (67,698)             (67,698)
Ending balance at Dec. 31, 2018 $ 370,567   $ 4   $ 573,183   $ (67) $ (202,553)
Ending balance, shares at Dec. 31, 2018     40,288,949